ESR1 and breast carcinoma: Inrecent years, studies have been conducted to evaluate the anti-cancer effect of silybin.We studied the effect of silybin and silybin-phosphatidylcholine on ESR1 and ESR2 geneexpression and viability in the T47D breast cancer cell line.